Back to search

Article

In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands

2025-09-17

Abstract excerpt

<h4>ABSTRACT</h4> APOE4, the major genetic risk factor for Alzheimer’s disease (AD), and ABCA1, required for lipidation of APOE are gene products of the liver X receptor (LXR) receptor. LXR agonists have been validated in animal models as therapeutics for AD, atherosclerosis, and many other diseases. Clinical progress has been thwarted by unwanted hepatic lipogenesis. Structurally diverse LXR ligands were profile...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e3d3860-f5ea-5b9a-aa52-6a11719115fe
DOI
10.1101/2025.09.12.675753
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligandsDOI 10.1101/2025.09.12.675753
Select a neighboring publication to make it the new centre.